Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Assets (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -9.92%
Dec 31, 2025 7.42%
Sep 30, 2025 9.58%
Jun 30, 2025 7.65%
Mar 31, 2025 2.46%
Dec 31, 2024 8.21%
Sep 30, 2024 5.96%
Jun 30, 2024 3.84%
Mar 31, 2024 -7.26%
Dec 31, 2023 26.47%
Sep 30, 2023 7.17%
Jun 30, 2023 4.89%
Mar 31, 2023 -1.91%
Dec 31, 2022 -0.79%
Sep 30, 2022 2.45%
Jun 30, 2022 -3.31%
Mar 31, 2022 -7.18%
Dec 31, 2021 4.10%
Sep 30, 2021 -3.54%
Jun 30, 2021 -1.92%
Mar 31, 2021 -5.55%
Dec 31, 2020 -5.29%
Sep 30, 2020 41.36%
Jun 30, 2020 -5.03%
Mar 31, 2020 -4.94%
Dec 31, 2019 -6.75%
Sep 30, 2019 5.26%
Jun 30, 2019 58.51%
Mar 31, 2019 -12.54%
Dec 31, 2017 -32.15%
Sep 30, 2017 -10.59%
Jun 30, 2017 6.03%
Mar 31, 2017 60.73%
Dec 31, 2016 -35.44%
Sep 30, 2016 2.60%
Jun 30, 2016 -0.09%
Mar 31, 2016 30.39%
Dec 31, 2015 7.93%
Sep 30, 2015 10.62%
Jun 30, 2015 7.29%
Mar 31, 2015 -2.89%
Dec 31, 2014 12.27%
Sep 30, 2014 13.13%
Jun 30, 2014 -1.52%
Mar 31, 2014 3.13%
Dec 31, 2013 86.98%
Sep 30, 2013 12.44%
Jun 30, 2013 6.42%
Mar 31, 2013 7.59%
Dec 31, 2012 4.91%
Sep 30, 2012 22.07%
Jun 30, 2012 2.28%
Mar 31, 2012 -0.87%
Dec 31, 2011 15.05%
Sep 30, 2011 -3.01%